Cel-SCi & MONEY
One would think that M/B shareholders/posters would like to post about ways to increase shareholder value.
The company has no product or service unless/until the FDA says so.
To raise money it sells shares.
Would a CEO rather sell shares at a lower or higher price?
The higher the sale price the better for shareholders.
***There is another way to receive income and that is the resolution of arbitration.***
No shares need be sold and the money received could pay for all the remaining H&N P3.
MK is not expected to be useful in all types of cancer.
It's application is for **"hard" tumor** cancer types , such as : BREAST , PROSTRATE, COLON & H&N.
Every year there are 650,000 H&N cancer patients worldwide.
treating just 30% is ABOUT 200,000 annual patients OR *$10B* each and every year.
The "OTHER" applicable cancer types are 3-5 times the income of H&N.
1 ) Arbitration
2 ) continue H&N P3
3 ) Move annual shareholder meeting to late July
4 ) Vote down R/S
News 
Market Data 
Discover 
